Latest Breaking News On - Obes metab - Page 1 : comparemela.com

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials

Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesDrug administrationAmerican college of endocrinologyAmerican association of clinical endocrinologistsDevelopment of the instrumentClinical endocrinologistsAmerican collegePrefer adherenceObes relat disDiabetes endocrinolEnglj medIntern medSynth methodsRes methodolEffect modification analyses

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United statesGarcia soriaNevarez ruizJ clin endocrinolActa physiolEuropean association for the study of diabetesAmerican diabetes associationEuropean associationEnglj medDiabetes endocrinolObes metabEndocrinol metabClin endocrinol metab

How uncontrolled diabetes can damage your heart

Type 2 diabetes is strongly linked to heart disease, with studies showing that it is the leading cause of death among people with diabetes worldwide.

United statesVan gaalClin pharmacolColl cardiolEduc health promotNational institute of diabetesBody massNational instituteKidney diseasesDiabetes resHeart diseaseObes metabPi sunyer diabetes careRev clin pharmacolCurr atherosclerHigh blood pressure

4 Ways Type 2 diabetes can become a concern for people with diabetes

Type 2 diabetes can cause severe short-term and long-term complications, including kidney and nerve damage. Heart disease is the leading cause of death among people with type 2 diabetes.

United kingdomClin pharmacolEndocrinol lausanneVan gaalNational cohort of adultsNovo nordiskDiabetes unitedMellitus related all causeCardiovascular mortalityNational cohortIntj clinDiabetes resObes metabSunyer diabetes careRev clin pharmacolEconomic times news app

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJ clin endocrinolAbu dayyehJ physiol gastrointestDrug administrationAmerican collegeAmerican association of clinical endocrinologistsWorld obesity federationEuropean medicines agencyMcgraw hillObesity atlasClinical endocrinologistsGraw hillNew york cityEndocrinol metab